WO2005092069A8 - Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof - Google Patents
Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereofInfo
- Publication number
- WO2005092069A8 WO2005092069A8 PCT/US2005/009805 US2005009805W WO2005092069A8 WO 2005092069 A8 WO2005092069 A8 WO 2005092069A8 US 2005009805 W US2005009805 W US 2005009805W WO 2005092069 A8 WO2005092069 A8 WO 2005092069A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- chimeric
- pcv2
- nonpathogenic
- gene
- immunogenic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10061—Methods of inactivation or attenuation
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL05746811T PL1727915T3 (en) | 2004-03-25 | 2005-03-23 | Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
EP20050746811 EP1727915B1 (en) | 2004-03-25 | 2005-03-23 | Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
ES05746811.8T ES2543838T3 (en) | 2004-03-25 | 2005-03-23 | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
DK05746811.8T DK1727915T3 (en) | 2004-03-25 | 2005-03-23 | Chimeric infectious DNA clones, chimeric porcine circovira and uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/808,964 | 2004-03-25 | ||
US10/808,964 US7279166B2 (en) | 2001-12-12 | 2004-03-25 | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
Publications (4)
Publication Number | Publication Date |
---|---|
WO2005092069A2 WO2005092069A2 (en) | 2005-10-06 |
WO2005092069A3 WO2005092069A3 (en) | 2006-06-08 |
WO2005092069A8 true WO2005092069A8 (en) | 2007-05-03 |
WO2005092069A9 WO2005092069A9 (en) | 2014-10-23 |
Family
ID=35056773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/009805 WO2005092069A2 (en) | 2004-03-25 | 2005-03-23 | Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
Country Status (7)
Country | Link |
---|---|
US (6) | US7279166B2 (en) |
EP (1) | EP1727915B1 (en) |
DK (1) | DK1727915T3 (en) |
ES (1) | ES2543838T3 (en) |
PL (1) | PL1727915T3 (en) |
PT (1) | PT1727915E (en) |
WO (1) | WO2005092069A2 (en) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040224327A1 (en) * | 1996-10-30 | 2004-11-11 | Meulenberg Johanna Jacoba Maria | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
EP0839912A1 (en) * | 1996-10-30 | 1998-05-06 | Instituut Voor Dierhouderij En Diergezondheid (Id-Dlo) | Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
FR2772047B1 (en) * | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | GENOMIC SEQUENCE AND POLYPEPTIDES OF CIRCOVIRUS ASSOCIATED WITH PIGLET LOSS DISEASE (MAP), APPLICATIONS TO DIAGNOSIS AND TO PREVENTION AND / OR TREATMENT OF INFECTION |
CA2366072C (en) * | 1999-03-08 | 2007-07-10 | Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. | Prrsv vaccines |
CA2370372C (en) * | 1999-04-22 | 2009-02-24 | United States Department Of Agriculture | Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142 |
US7279166B2 (en) * | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
MXPA06015105A (en) * | 2004-06-18 | 2007-03-26 | Univ Minnesota | Identifying virally infected and vaccinated organisms. |
US7632636B2 (en) * | 2004-09-21 | 2009-12-15 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome isolates and methods of use |
US7833707B2 (en) * | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
UA95602C2 (en) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Pcv2 immunogenic compositions and methods of producing such compositions |
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
US8110390B2 (en) | 2005-06-24 | 2012-02-07 | Regents Of The University Of Minnesota | PRRS viruses, infectious clones, mutants thereof, and methods of use |
RU2488407C2 (en) | 2005-12-29 | 2013-07-27 | Берингер Ингельхайм Ветмедика, Инк. | Polyvalent immunogenic compositions pcv2 and methods for producing such compositions |
DK2371382T3 (en) * | 2005-12-29 | 2016-06-13 | Boehringer Ingelheim Vetmedica Inc | Use of a PCV2 immunogenic composition to reduce the clinical signs in swine |
WO2008064299A2 (en) * | 2006-11-22 | 2008-05-29 | Boehringer Ingelheim Vetmedica, Inc. | Methods of reducing porcine circovirus-associated disease outbreaks |
US20100129397A1 (en) * | 2006-12-11 | 2010-05-27 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
BRPI0721083A2 (en) | 2006-12-15 | 2014-02-25 | Boehringer Ingelheim Vetmed | PCV2 ANTIGEN PIG TREATMENT |
EP1941903A1 (en) * | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
EP1958644A1 (en) * | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
WO2008121958A1 (en) * | 2007-04-02 | 2008-10-09 | Boehringer Ingelheim Vetmedica, Inc. | Use of prrsv vaccines to reduce pcv2 viremia |
US7666585B2 (en) * | 2007-06-15 | 2010-02-23 | Protatek International, Inc. | Construction of chimera PRRSV, compositions and vaccine preparations |
US20090017064A1 (en) * | 2007-07-10 | 2009-01-15 | Wyeth | Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
EP2217271B1 (en) * | 2007-11-06 | 2016-05-04 | Zoetis Services LLC | Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine |
BRPI0821286A8 (en) * | 2007-12-21 | 2017-08-15 | Wyeth Llc | METHODS AND COMPOSITIONS FOR IMMUNIZING PIGS AGAINST SWINE CIRCOVIRUS |
AU2008347235A1 (en) * | 2007-12-31 | 2009-07-16 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 ORF2 virus like particle with foreign amino acid insertion |
WO2009126356A2 (en) * | 2008-01-23 | 2009-10-15 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions |
NZ588639A (en) * | 2008-04-16 | 2012-10-26 | Virginia Tech Intell Prop | CHIMERIC PORCINE CIRCOVIRUS PCV2Gen-1Rep AND USES THEREOF |
JP5619004B2 (en) * | 2008-08-25 | 2014-11-05 | ベーリンガーインゲルハイム フェトメディカ インコーポレイテッド | Highly pathogenic pig breeding / respiratory syndrome (HPPRRS) vaccine |
AR078253A1 (en) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | METHODS TO REDUCE ANTIVIRICAL ACTIVITY IN PCV-2 COMPOSITIONS AND PCV-2 COMPOSITIONS WITH BETTER IMMUNOGENICITY |
KR20110090711A (en) | 2010-02-04 | 2011-08-10 | 녹십자수의약품(주) | Novel porcine circovirus type 2 and use thereof |
PT2547770T (en) | 2010-03-16 | 2020-03-04 | Virginia Tech Intellectual Properties Inc | Live attenuated chimeric porcine circovirus vaccine |
JP5902160B2 (en) * | 2010-07-08 | 2016-04-13 | ユナイテッド・バイオメディカル・インコーポレーテッドUnited Biomedical Incorporated | Designer peptide-based PCV2 vaccine |
TWI508974B (en) | 2010-12-22 | 2015-11-21 | Sbc Virbac Ltd | Porcine circovirus type 2, immunogenic composition containing the same, test kit, and application thereof |
UA112860C2 (en) | 2011-02-17 | 2016-11-10 | Бьорінгер Інгельхайм Ветмедіка Гмбх | METHOD OF RECRUITING PRRSV ON A COMMERCIAL SCALE |
PL2959916T3 (en) | 2011-02-17 | 2019-05-31 | Boehringer Ingelheim Vetmedica Gmbh | Novel european prrsv strain |
WO2013017570A1 (en) | 2011-07-29 | 2013-02-07 | Boehringer Ingelheim Vetmedica Gmbh | Novel prrs virus inducing type i interferon in susceptible cells |
US9187731B2 (en) | 2011-07-29 | 2015-11-17 | Boehringer Ingelheim Vetmedica Gmbh | PRRS virus inducing type I interferon in susceptible cells |
US20150093403A1 (en) * | 2012-04-03 | 2015-04-02 | The Trustees Of Columbia University In The City Of New York | Canine circovirus sequences and uses thereof |
UA114504C2 (en) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | PCV, MYCOPLASMA HYOPNEUMONIA AND PRRS COMBINED VACCINE |
US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
UA114503C2 (en) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | PCV AND MYCOPLASMA HYOPNEUMONIA COMBINED VACCINE |
EP2774996B1 (en) * | 2013-03-04 | 2016-08-10 | Technische Universität Kaiserslautern | A method for production of single-stranded nucleic acids |
EP2968513A2 (en) | 2013-03-15 | 2016-01-20 | Boehringer Ingelheim Vetmedica, Inc. | Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use |
JP6821429B2 (en) | 2013-09-25 | 2021-01-27 | ゾエティス・サービシーズ・エルエルシー | PCV2B branched vaccine composition and usage |
US9505808B2 (en) | 2013-10-02 | 2016-11-29 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 ORF2 protein variant and virus like particles composed thereof |
CN104109704B (en) * | 2014-07-09 | 2016-05-04 | 福州大学 | A kind of isolation and purification method of Recombinant Swine PCV-II capsid protein inclusion body |
CN105648118B (en) * | 2016-03-14 | 2019-09-10 | 扬州大学 | A kind of method of TaqMan fluorescence quantitative PCR detection chimeric porcine circovirus type 1-2 |
CN109706127B (en) * | 2019-01-28 | 2022-08-02 | 西北农林科技大学 | Construction method of porcine circovirus type 2 low virulent strain PCV2RMA |
WO2021018806A1 (en) * | 2019-07-26 | 2021-02-04 | Ceva Sante Animale | Igg-depleted porcine serum and the uses thereof |
US20220265808A1 (en) * | 2019-07-26 | 2022-08-25 | Ndsu Research Foundation | A porcine circovirus type 2 (pcv2) vaccine |
CN112574963B (en) * | 2020-12-30 | 2023-07-04 | 西北农林科技大学 | NPM1 binding region mutation PCV2 virus and preparation method and application thereof |
CN114736310B (en) * | 2022-06-10 | 2022-10-28 | 北京华夏兴洋生物科技有限公司 | Protein and biological material for producing circovirus type 2 virus-like particles and application |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2769321B1 (en) | 1997-10-03 | 2001-10-26 | Merial Sas | NEW PIG CIRCOVIRUSES, VACCINES AND DIAGNOSTIC REAGENTS |
FR2769322B1 (en) | 1997-10-03 | 2002-03-08 | Merial Sas | NEW PORCINE CIRCOVIRUSES, VACCINES AND DIAGNOSTIC REAGENTS |
FR2781159B1 (en) | 1998-07-06 | 2000-10-06 | Merial Sas | CIRCOVIRUS VACCINE AND PIG PARVOVIRUS |
US6391314B1 (en) | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
UA78180C2 (en) | 1997-10-03 | 2007-03-15 | Меріаль | Porcine circovirus, vaccines and diagnostic reagents |
US6517843B1 (en) * | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
FR2772047B1 (en) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | GENOMIC SEQUENCE AND POLYPEPTIDES OF CIRCOVIRUS ASSOCIATED WITH PIGLET LOSS DISEASE (MAP), APPLICATIONS TO DIAGNOSIS AND TO PREVENTION AND / OR TREATMENT OF INFECTION |
US6287856B1 (en) | 1998-03-13 | 2001-09-11 | University Of Georgia Research Foundation, Inc. | Vaccines against circovirus infections |
US6268601B1 (en) * | 1998-12-02 | 2001-07-31 | Honeywell International Inc. | Apparatus for determing the position of a rotating shaft |
US6497883B1 (en) | 1999-06-10 | 2002-12-24 | Merial | Porcine circovirus recombinant poxvirus vaccine |
US6943152B1 (en) * | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
EP1311698A2 (en) | 2000-05-03 | 2003-05-21 | University Of Guelph | Porcine adenovirus type 5 vector and vaccine |
KR20030036194A (en) | 2000-05-24 | 2003-05-09 | 메리알 | Porcine reproductive and respiratory syndrome virus (prrsv) recombinant poxvirus vaccine |
MXPA02012352A (en) | 2000-06-15 | 2004-09-06 | Purdue Research Foundation | Vaccine for congenital tremors in pigs. |
US20020003112A1 (en) * | 2000-07-07 | 2002-01-10 | Golden Josh H. | Process and apparatus for removal of heavy metals from wastewater |
DE10044648A1 (en) | 2000-09-08 | 2002-03-21 | Aventis Behring Gmbh | Process for the propagation or removal of Cirocoviruses from biological material |
JP4038127B2 (en) | 2001-03-27 | 2008-01-23 | ユニバーシティ オブ サスカチュワン | Circovirus culture method |
AUPR567401A0 (en) | 2001-06-14 | 2001-07-12 | University Of Melbourne, The | Circovirus vaccines |
US20030147914A1 (en) * | 2001-07-02 | 2003-08-07 | Pfizer Inc. | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
US7279166B2 (en) * | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7276353B2 (en) * | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
PT2547770T (en) * | 2010-03-16 | 2020-03-04 | Virginia Tech Intellectual Properties Inc | Live attenuated chimeric porcine circovirus vaccine |
-
2004
- 2004-03-25 US US10/808,964 patent/US7279166B2/en not_active Expired - Lifetime
-
2005
- 2005-03-23 PL PL05746811T patent/PL1727915T3/en unknown
- 2005-03-23 DK DK05746811.8T patent/DK1727915T3/en active
- 2005-03-23 EP EP20050746811 patent/EP1727915B1/en active Active
- 2005-03-23 ES ES05746811.8T patent/ES2543838T3/en active Active
- 2005-03-23 WO PCT/US2005/009805 patent/WO2005092069A2/en active Search and Examination
- 2005-03-23 PT PT57468118T patent/PT1727915E/en unknown
-
2007
- 2007-08-15 US US11/893,182 patent/US7575752B2/en not_active Expired - Lifetime
-
2009
- 2009-08-11 US US12/539,540 patent/US8058048B2/en not_active Expired - Lifetime
-
2011
- 2011-10-07 US US13/268,008 patent/US9211324B2/en not_active Expired - Lifetime
-
2015
- 2015-11-13 US US14/940,799 patent/US9889187B2/en not_active Expired - Lifetime
-
2018
- 2018-01-19 US US15/875,892 patent/US10507238B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7575752B2 (en) | 2009-08-18 |
EP1727915A2 (en) | 2006-12-06 |
US20080226666A1 (en) | 2008-09-18 |
US8058048B2 (en) | 2011-11-15 |
US20180147275A1 (en) | 2018-05-31 |
PT1727915E (en) | 2015-09-11 |
US9889187B2 (en) | 2018-02-13 |
US7279166B2 (en) | 2007-10-09 |
WO2005092069A3 (en) | 2006-06-08 |
WO2005092069A2 (en) | 2005-10-06 |
PL1727915T3 (en) | 2015-10-30 |
US20160129103A1 (en) | 2016-05-12 |
US20130149334A1 (en) | 2013-06-13 |
US20100055122A1 (en) | 2010-03-04 |
US9211324B2 (en) | 2015-12-15 |
US20040253270A1 (en) | 2004-12-16 |
US10507238B2 (en) | 2019-12-17 |
EP1727915B1 (en) | 2015-05-13 |
WO2005092069A9 (en) | 2014-10-23 |
EP1727915A4 (en) | 2008-12-24 |
DK1727915T3 (en) | 2015-08-03 |
ES2543838T3 (en) | 2015-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005092069A3 (en) | Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof | |
WO2003049703A8 (en) | Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof | |
MX2020005451A (en) | Adeno-associated virus variant capsids and use for inhibiting angiogenesis. | |
WO2011116094A3 (en) | Live attenuated chimeric porcine circovirus vaccine | |
NZ748395A (en) | Adeno-associated virus variant capsids and methods of use thereof | |
UA106587C2 (en) | Chimeric porcine circovirus pcv2gen-1rep and its use | |
WO2017187277A3 (en) | Chimeric porcine circovirus type 2 (pcv2) vaccines | |
AU2007353480B2 (en) | Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection | |
CY1116098T1 (en) | CHEMICAL POLYMERIC POLYMERIC CLONES OF SWINE CIRCULATION AND USE OF THESE | |
MY186651A (en) | Adeno-associated virus variant capsids and methods of use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005746811 Country of ref document: EP |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2005746811 Country of ref document: EP |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |